13/1/2025, 1:30:05 pm

Vivo Biotech Consolidated December 2024 Net Sales at Rs 12.21 crore

Vivo Biotech's consolidated quarterly numbers show a decline in net sales by 4.95% to Rs 12.21 crore and net profit by 37.92% to Rs 0.82 crore in December 2024 compared to the same period last year. Vivo Biotech's EPS decreased to Rs 0.55 from Rs 0.89 in December 2023. Vivo Biotech shares closed at 46.83 on January 10, 2025, with 24.45% returns over the last 6 months.